Finzati - Logo
ACAD logo

ACADIA Pharmaceuticals Inc.

ACAD • Biotechnology
$28.02
▲ +0.16 (+0.57%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$4.84B
Growth
1.8%
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 36.5%Positive revenue growth · 20.3%Positive free cash flow · 0.62Reasonable earnings multiple · 11.57Manageable debt level · 0.04
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:43 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$28.02
Change0.57%
Shares Out172.89M
Market Cap$4.84B
Enterprise Value$3.89B
52W Range19.69 - 29.48
Beta0.80
P/E12.73
P/S4.25
P/B3.71
P/FCF33.27
EV/Sales3.41

Investment DNA

How strong this company looks for long-term investors

64
out of 100
Business Quality
Margins, moat, returns
73/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
54/100
Why this score▼
Stable or improving margins · 36.5%Positive revenue growth · 20.3%Positive free cash flow · 0.62Reasonable earnings multiple · 11.57Manageable debt level · 0.04Healthy liquidity · 3.83

Analyst view

Analyst sentiment and price target

ACAD
Analyst sentiment
Based on 37 analyst votes · 2026-09-05
84/100
Bullish
Bullish
26
Hold
10
Bearish
1
Price Target
2026-08-07
Low
$14.50
Mean
$31.39
Median
$35.00
High
$37.00

Company Overview

IPO: 5/27/2004
Industry: Biotechnology
P/B i: 3.71
Debt / Equity i: 0.04
Operating Margin: 9.78%
Net Margin: 36.49%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.04
Current Ratio: 3.83
Quick Ratio: 3.71
Status: Good

Insider Transactions

Recent executive and insider activity

Thompson Elizabeth H.Z.
Transaction: 07/30/2026
SELL
Change
-50
Price
$26.17
Filing
07/31/2026
Type
SELL
Thompson Elizabeth H.Z.
Transaction: 07/29/2026
SELL
Change
-32,272
Price
Not reported
Filing
07/31/2026
Type
SELL
Thompson Elizabeth H.Z.
Transaction: 07/29/2026
BUY
Change
+32,272
Price
Not reported
Filing
07/31/2026
Type
BUY